From: A gender-related action of IFNbeta-therapy was found in multiple sclerosis
Cytokines(pg/ml∘U/ml | Treated patients | |||
---|---|---|---|---|
IDC | IDC-LPS | |||
Man | Women | Man | Women | |
IL10 | 5.3 ± 0.1a | 3.3 ± 0.9 | 73.9 ± 37.5 | 41.2 ± 7.9 |
IL12p70 | 0 ± 0.02 | 0.13 ± 0.13b | 3.3 ± 3.1 | 4.5 ± 1.3i |
IL12p40 | 58.2 ± 11.4 | 35.8 ± 5.9d | 3834 ± 796l | 3863 ± 260m |
TGFβ | 22156 ± 1091e | 21792 ± 701f | 20701 ± 1103n | 20164 ± 633p |
∘sCD30 | 7.01 ± 0.4g | 6.9 ± 1.1h | 13.5 ± 1.1q | 14.7 ± 1.1r |
Cytokines(pg/ml ∘ U/ml | Untreated patients | |||
IDC | IDC-LPS | |||
Man | Women | Man | Women | |
IL10 | 0.6 ± 0.6a | 1.1 ± 0.5 | 27.5 ± 19.2 | 55.8 ± 13.1 |
IL12p70 | 0.37 ± 0.9c | 2.9 ± 0.6b,c | 9.7q ± 6.5 | 17.1 ± 3.8i |
IL12p40 | 51.9 ± 6.8 | 63.7 ± 7.3d | 5999 ± 277l | 5094 ± 647m |
TGFβ | 16582 ± 813e | 16400 ± 575f | 14726 ± 642n | 14210 ± 601p |
∘sCD30 | 27.2 ± 24g | 26.8 ± 5h | 36.9 ± 3.2q | 38.1 ± 3.5r |